{
    "2018-02-22": [
        [
            {
                "time": "",
                "original_text": "龙马风格主导“鸡飞”行情16股有望继续“狗跳”",
                "features": {
                    "keywords": [
                        "龙马风格",
                        "鸡飞",
                        "狗跳"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：2018年新气象 新医药 看好商业健康险和创新药物的快速发展",
                "features": {
                    "keywords": [
                        "医药生物",
                        "商业健康险",
                        "创新药物",
                        "快速发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:看好估值合理的子行业龙头,重点推荐恒瑞医药、长春高新、美年健康等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值合理",
                        "子行业龙头",
                        "恒瑞医药",
                        "长春高新",
                        "美年健康"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}